Connection

Maria Lopes-Virella to Arteriosclerosis

Back to Details
This is a "connection" page, showing publications Maria Lopes-Virella has written about Arteriosclerosis.
Maria Lopes-Virella
Connection Strength
1.909
Arteriosclerosis
  1. Humoral immunity and atherosclerosis. Nat Med. 2003 Mar; 9(3):243-4; author reply 244-5.
    View in: PubMed
    Score: 0.201
  2. Chlamydophila pneumoniae infection of human aortic endothelial cells induces the expression of FC gamma receptor II (FcgammaRII). Clin Immunol. 2002 Sep; 104(3):265-73.
    View in: PubMed
    Score: 0.194
  3. The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA. Atherosclerosis. 2000 Sep; 152(1):107-15.
    View in: PubMed
    Score: 0.169
  4. Cytokines, modified lipoproteins, and arteriosclerosis in diabetes. Diabetes. 1996 Jul; 45 Suppl 3:S40-4.
    View in: PubMed
    Score: 0.127
  5. Atherosclerosis and autoimmunity. Clin Immunol Immunopathol. 1994 Nov; 73(2):155-67.
    View in: PubMed
    Score: 0.113
  6. Immune mechanisms of atherosclerosis in diabetes mellitus. Diabetes. 1992 Oct; 41 Suppl 2:86-91.
    View in: PubMed
    Score: 0.098
  7. Lipoproteins and immune responses in the vascular wall and their contribution to atherosclerosis in diabetes. Metabolism. 1992 May; 41(5 Suppl 1):11-5.
    View in: PubMed
    Score: 0.095
  8. Immune mechanisms in the pathogenesis of atherosclerosis. Adv Exp Med Biol. 1991; 285:383-92.
    View in: PubMed
    Score: 0.086
  9. Diabetes, autoimmunity, and arteriosclerosis. Clin Immunol Immunopathol. 1989 Sep; 52(3):414-20.
    View in: PubMed
    Score: 0.079
  10. A review of the development of large-vessel disease in diabetes mellitus. Am J Med. 1988 Nov 28; 85(5A):113-8.
    View in: PubMed
    Score: 0.075
  11. Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation. J Exp Med. 1988 Sep 01; 168(3):1041-59.
    View in: PubMed
    Score: 0.074
  12. Infections and atherosclerosis. Transplant Proc. 1987 Aug; 19(4 Suppl 5):26-35.
    View in: PubMed
    Score: 0.068
  13. Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes. Metabolism. 2005 Apr; 54(4):453-9.
    View in: PubMed
    Score: 0.058
  14. Lipoprotein autoantibodies: measurement and significance. Clin Diagn Lab Immunol. 2003 Jul; 10(4):499-505.
    View in: PubMed
    Score: 0.051
  15. Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL. Clin Immunol. 2002 Oct; 105(1):81-92.
    View in: PubMed
    Score: 0.049
  16. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation. 2002 May 07; 105(18):e138-43.
    View in: PubMed
    Score: 0.047
  17. Fc-gamma receptor cross-linking by immune complexes induces matrix metalloproteinase-1 in U937 cells via mitogen-activated protein kinase. Arterioscler Thromb Vasc Biol. 2000 Dec; 20(12):2533-8.
    View in: PubMed
    Score: 0.043
  18. Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes. Diabetes. 2000 Jun; 49(6):1033-41.
    View in: PubMed
    Score: 0.042
  19. Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler Thromb Vasc Biol. 1999 Nov; 19(11):2640-7.
    View in: PubMed
    Score: 0.040
  20. Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages. Arterioscler Thromb Vasc Biol. 1999 Jul; 19(7):1600-7.
    View in: PubMed
    Score: 0.039
  21. Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls. Clin Immunol Immunopathol. 1997 Oct; 85(1):73-82.
    View in: PubMed
    Score: 0.035
  22. Modified lipoproteins, cytokines and macrovascular disease in non-insulin-dependent diabetes mellitus. Ann Med. 1996 Aug; 28(4):347-54.
    View in: PubMed
    Score: 0.032
  23. Modification of lipoproteins in diabetes. Diabetes Metab Rev. 1996 Apr; 12(1):69-90.
    View in: PubMed
    Score: 0.031
  24. Low density lipoprotein metabolism in human macrophages stimulated with microbial or microbial-related products. Arteriosclerosis. 1987 Mar-Apr; 7(2):176-84.
    View in: PubMed
    Score: 0.017
  25. Immunological and microbiological factors in the pathogenesis of atherosclerosis. Clin Immunol Immunopathol. 1985 Dec; 37(3):377-86.
    View in: PubMed
    Score: 0.015
  26. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med. 1983 Nov 30; 75(5B):67-80.
    View in: PubMed
    Score: 0.013
  27. Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care. 1981 Jan-Feb; 4(1):121-33.
    View in: PubMed
    Score: 0.011
  28. Vascular disease in diabetes: pathophysiological mechanisms and therapy. Arch Intern Med. 1979 Feb; 139(2):225-30.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.